Figure legends
Fig. 1. Comprehensive spectrum of adverse reactions related to
sugammadex reported by VigiBase with positive results from the
disproportionate analysis. IC025 > 3 was
considered a significant association signal, indicating that the adverse
reactions have a strong correlation with sugammadex use.
Fig. 2. Results of the analysis of variance of IC025values of adverse drug reactions in each age group. The ANOVA test
showed statistically significant differences (P < 0.01)
between age groups, indicating that the overall intensity of adverse
reaction signals in the 0–17 years group was the highest.
Fig. 3. Spectrum of adverse drug reactions (ADRs) in different age
groups. No signal means no related ADR in this age group or ADR with
IC025 < 0.